Pharmaceuticals

FDA Approves Botanix Pharmaceuticals’ Sofdra for Treatment of Primary Axillary Hyperhidrosis

bexib
By bexib 0 Min Read

Sofdra’s approval marks the first chemical entity approved by the FDA for the treatment of primary axillary hyperhidrosis.

You Might Also Like

APL and CurifyLabs Partner to Support Patients with 3D Printed Medical Technology

Phase 2 PREDICT-ILD Imaging Study in Interstitial Lung Disease Begins

New ways to determine drug value with health equity in mind

Melissa Krebs Shares Gersana’s Vision for Innovative Wound Care Solutions

Zongertinib demonstrates high objective response rates in previously treated advanced non-small cell lung cancer

Share This Article
Previous Article Chart: Top e-commerce sites by traffic, Q2 2024
Next Article Organic Farming vs. Natural Farming (ZBNF): Key Principles and Differences
Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Season 2024: Exceeding expectations at Borghese Contemporary Hotel
Hospitality & Tourism
JPMorgan and Bank of America respond to CFPB lawsuit
Banking
Zell says CFPB lawsuit against big banks is ‘regulatory overreach’
Banking
Insurance News: Looking back at 2024 | Insurance Blog
Insurance